(2R*,3AS*,10AR*)-2-TERT.-BUTYL-2,3,3A,5,6,7,8,10A-OCTAHYDROCYCLOPENTA-[D]-PYRIDO-[1,2-A]-PYRIMIDIN-10(1H)-ONE
Compound with spectra: 1 NMR
![(2R*,3AS*,10AR*)-2-TERT.-BUTYL-2,3,3A,5,6,7,8,10A-OCTAHYDROCYCLOPENTA-[D]-PYRIDO-[1,2-A]-PYRIMIDIN-10(1H)-ONE](/api/compound/CJjWeS5go0r.png?ph=true&h=300&w=458 "(2R*,3AS*,10AR*)-2-TERT.-BUTYL-2,3,3A,5,6,7,8,10A-OCTAHYDROCYCLOPENTA-[D]-PYRIDO-[1,2-A]-PYRIMIDIN-10(1H)-ONE")
| SpectraBase Compound ID | CJjWeS5go0r |
|---|---|
| InChI | InChI=1S/C15H24N2O/c1-15(2,3)10-8-11-12(9-10)16-13-6-4-5-7-17(13)14(11)18/h10-12H,4-9H2,1-3H3/t10-,11-,12+/m0/s1 |
| InChIKey | ULABJHDLUSULAG-SDDRHHMPSA-N |
| Mol Weight | 248.37 g/mol |
| Molecular Formula | C15H24N2O |
| Exact Mass | 248.188863 g/mol |
| Enantiomer InChIKey | ULABJHDLUSULAG-UTUOFQBUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(2R*,3AS*,11AR*)-2-TERT.-BUTYL-1,2,3,3A,5,6,7,8,9,11A-DECAHYDROCYCLOPENTA-[D]-AZEPINO-[1,2-A]-PYRIMIDIN-11-ONE
(4AR*,6R*,7AS*)-6-TERT.-BUTYL-3-PHENYL-1,2,3,4A,5,6,7,7A-OCTAHYDROCYCLOPENTA-[D]-PYRIMIDINE-2,4-DIONE
(4AR*,6R*,7AS*)-1-BENZYL-6-TERT.-BUTYL-1,2,3,4A,5,6,7,7A-OCTAHYDROCYCLOPENTA-[D]-PYRIMIDINE-2,4-DIONE
2,6-Bis-trifluoromethyl-1,3a,4,4a,5,7a,8,8a,8b,8c-decahydro-1,3,5,7-tetraaza-cyclopenta[def]fluorene
(4AR*,6R*,7AS*)-1-BENZYL-6-TERT.-BUTYL-2-THIOXO-1,2,3,4A,5,6,7,7A-OCTAHYDROCYCLOPENTA-[D]-PYRIMIDIN-4-ONE
2,3,6,7,8,9,10-HEPTAHYDRO-2-METHYL-4H-AZEPINO[1,2-a]FURO[2,3-d]PYRIMIDIN-4-ONE
N,N'-Bis{[(1S,4R)-7,7-dimethyl-2-oxonorborn-1-yl]carbonyl}-4,4'-bipiperidine
7-METHYL-1,2,3,4,5,6,7,8-OCTAHYDRO-11H-PYRIDO-[2,1-B]-QUINAZOLIN-11-ONE
4-(5-methyl-1,3-dioxooctahydro-2H-isoindol-2-yl)phenyl 3-nitrobenzoate
4-(2,6-Dimethyl-4-nitro-3-phenyl-1-cyclohexen-1-yl)morpholine
| Title | Journal or Book | Year |
|---|---|---|
| tert-Butylcyclopentane Derivatives. Part 8. Synthesis of tert-Butylcyclopentane-fused Pyrimidin-4-ones | HETEROCYCLES | 1996 |